Fish oil in diabetic nephropathy

Diabetes Care

Volumn 19, Issue 11, 1996, Pages 1214-1219

  Rossing, Peter ^a   Hansen, Birgitte V ^a   Nielsen, Flemming S ^b   Myrup, Bjarne ^a   Holmer, Gunhild ^a,b   Parving, Hans Henrik ^a  

^a STENO DIABETES CENTER   (Denmark)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; ESKISOL; FISH OIL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OLIVE OIL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DOUBLE BLIND PROCEDURE; DYSLIPIDEMIA; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; ORAL DRUG ADMINISTRATION; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0029955092     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.11.1214     Document Type: Article

References (48)

1. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Decken T: Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study Diabetologia 25:496-501,1983
2. Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR: The changing natural history of nephropathy in type 1 diabetes. Am JMed 78:785-794, 1985
3. Borch-Johnsen K, Andersen PK, Decken T: The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28:590-596,1985
4. Gall M-A, Rossing P, Hommel E, Voldsgaard AI, Andersen P, Nielsen FS, Dyerberg J, Parving H-H: Apolipoprotein(a) in insulin-dependent diabetic patients with and without diabetic nephropathy. Scand] din Lab Invest 52:513-521,1992
5. Parving H-H, Hommel E, Mathiesen ER, Skott P, Edsberg B, Bahnsen M, Lauritzen M, Hougaard P, Lauritzen E: Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin-dependent diabetes. Br Med J 296:156-160,1988
6. Borch-Johnsen K, Kreiner S: Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. BrMedJ 294:1651-1654,1987
7. Mogensen CE: Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J 285:685-688,1982
8. Parving H-H, Andersen AR, Smidt UM, Svendsen PA: Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet 1:1175-1179, 1983
9. Björck S, Mulec H, Johnsen SA, Norden G, Aurell M: Renal protective effect of enalapril in diabetic nephropathy. Br MedJ 304:339-343,1992
10. Lewis E, Hunsicker L, Bain R, Rhode R: The effect of angiotensin-convertingenzyme inhibition on diabetic nephropathy. N EnglJ Med 329:1456-1462,1993
11. Parving H-H, Hommel E: Prognosis in diabetic nephropathy. BrMedJ299:230-233, 1989
12. Mathiesen ER, Borch-Johnsen K, Jensen DV, Decken T: Improved survival in patients with diabetic nephropathy. Diabetologia 32:884-886,1989
13. Pan-ing H-H, Rossing P: The use of antihypertensive agents in prevention and treatment of diabetic nephropathy. Curr Opin Nephrol Hypertens 3:292-300,1994
14. Parving H-H, Hommel E, Nielsen MD, Giese J: Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy. BrMedJ 299:533-536,1989
15. Viberti GC, Bilous R\V, Mackintosh D, Bending JJ, Keen H: Long term correction of hyperglycaemia and progression of renal failure in insulin dependent diabetes. BrMedJ 286:598-602,1983
16. Hommel E, Andersen P, Gall M-A, Nielsen FS, Jensen B, Rossing P, DyerbergJ, Pan-ing H-H: Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy. Diabetologia 35: 447-451,1992
17. Walker JD, Bending JJ, Dodds RA, Mattock MB, Murrells TJ, Keen H, Viberti GC: Restriction of dietary protein and progression of renal failure in diabetic nephropathy. Lancet ii:1411-1415, 1989
18. Pan-ing H-H: Low-protein diet and progression of renal disease in diabetic nephropathy (Letter). Lancet 335:411,1990
19. De Caterina R, Caprioli R, Giannessi D, Sicari R, Galli C, Lazzerini G, Bemini W, Carr L, Rindi P: n-3 Fatty acids reduce proteinuria in patients with chronic glomerular disease. Kidney Int 44:843-850,1993
20. Donadio JV, Bergstralh EJ, Offord KP, Spencer DC, Holley KE: A controlled trial of fish oil in IgA nephropathy. N Engl] Med 331:1194-1199,1994
21. van der Heide JJH, Bib HJG, Donker JM, Wilmink JM, Tegzess AM: Effect of dietary fish oil on renal function and rejection in cyclosporine-treated recipients of renal transplants. N Eng! J Med 329:769-773, 1993
22. De Caterina R, Endres S, Kristensen SD, Schmidt EB: n-3 fatty acids and renal diseases. Am] Kidney Dis 24:397-415, 1994
23. Bröchner-Mortensen J, Rôdbro P: Selection of routine method for determination of glomerular filtration rate in adult patients. Scand] Clin Lab Invest 36:35-45,1976
24. Bröchner-Mortensen J: A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 30:271-274,1972
25. Feldt-Rasmussen B, Dinesen B, Decken M: Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest 45:539-544, 1985
26. Kofoed-Enevoldsen A, Jensen K, Beck TC: Measuring urinary IgG and lgG4 excretion (Letter). CîinChem37:1136, 1991
27. White WB, Pickering TG, Morganroth J, James GD, McCabe EJ, Moucha O, Hunter H: A multicenter evaluation of the A&D TM-2420 ambulatory blood pressure recorder. AmJ Hypertens 4:890-896,1991
28. Jensen T, Decken M, Dawnay A, FeldtRasmussen B: Micro-ELlSA for the quantitation of human urinary and serum retinol-binding protein. Diabetes Res 10:93-95, 1989
29. Isaksson B: Urinary nitrogen output as a validity test in dietary surveys. Am J Clin Nutr 33:4-5,1980
30. Maroni BJ, Steinman Tl, Mitch WE: A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int 27:58-65,1985
31. Larsen K: Creatinine assay by a reactionkinetic principle. Clin Chim Acta 41:209-217,1972
32. Friedewald WT, Levy RI, Frederickson DS: Estimation of the concentration of lowdensity lipoprotein cholesterol in plasma, without use of the preparative ultracentrifugation. Clin Chem 18:499-502,1972
33. Jensen T, Stender S, Goldstein K, Holmer G, Decken T: Partial normalization by dietary cod-liver oil of increased microvascular albumin leakage in patients with insulin-dependent diabetes and albuminuria. N EnglJMed 321:1572-1577, 1989
34. Appel LJ, Miller ER, Seidler AJ, Whelton PK: Does supplementation of diet with 'fish oil' reduce blood pressure? A metaanalysis of controlled clinical trials. Arch Intern Med 53:1429-1438,1993
35. Berthoux FC, Guerin C, Burgard G, Berthoux P, Alamartine E: One-year randomized controlled trial with omega-3 fatty acid-fish oil in clinical renal transplantation. Trans Proc 24:2578-2582, 1992
36. Clark \VF, Parbtani A: Omega-3 fatty acid supplementation in clinical and experimental lupus nephritis. Am J Kidney Dis 23:644-647,1994
37. Bennet WM, Walker RG, Kincaid-Smith P: Treatment of IgA nephropathy with eicosapentaenoic acid (EPA): a two-year prospective trial. Clin Nephrol 31:128-131,1989
38. Pettersson EE, Rekola S, Berglund L, Sundqvist KG, Angelin B, Diczfalusy U, Björkheim L, Bergström J: Treatment of IgA nephropathy with omega-3-polyunsaturated fatty acids: a prospective, double-blind, randomized study. Qin Nephrol 41:183-190,1994
39. Jacobson HR: Chronic renal failure: pathophysiology. Lancet 338:419-423, 1991
40. Pairing H-H, Rossing P, Hommel E, Smidt UM: Angiotensin converting enzyme inhibition in diabetic nephropathy: ten years experience. Am J Kidney Dis 26:99-107, 1995
41. Rossing P, Hommel E, Smidt UM, Pan-ing H-H: Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment. Diabetologa 37:511-516,1994
42. Apperloo AJ, de Zeeuw D, de Jong PE: Short-term antiproteinuric response to antihypertensive treatment predicts longterm GFR decline in patients with nondiabetic renal disease. Kidney Int 45 (Suppl. 45):S174-S178,1994
43. Haines AP: Fish oil supplement in diabetics. Thromb Res 43:644-655,1986
44. Hamazaki T, Takazakura E, Osawa K, Urakaze M, Yano S: Reduction in microalbuminuria in diabetics by eicosapentaenoic acid ethyl ester. Lipids 25:541-545, 1990
45. Scharschmidt LA, Gibbsons NB, McGany L, Berger P, Axelrod M, Janis R, Ko YH: Effects of dietary fish oil on renal insufficiency in rats with subtotal nephrectomy. Kidney Int 32:700-709,1987
46. Landgraf-Leurs MMC, Drummer C, Fröschl H, Steinhuber R, von Schacky C, Landgraf R: Pilot study on omega-3 fatty acids in type I diabetes mellitus. Diabetes 39:369-375,1990
47. Joint National Committee on Detection E: The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC-V). Arch Intern Med 153:154-183,1993
48. American Diabetes Association: Treatment of hypertension in diabetes. Diabetes Care 16:1394-1401,1993